Robert Harrington to Serine Proteinase Inhibitors
This is a "connection" page, showing publications Robert Harrington has written about Serine Proteinase Inhibitors.
Connection Strength
0.165
-
Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes. Circulation. 2019 11 05; 140(19):1578-1589.
Score: 0.165